We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

Revolution Medicines, Inc. (NASDAQ:RVMD), a biotechnology company focused on developing novel therapies for RAS-dependent cancers, has been garnering significant attention from analysts and investors ...

Revolution Medicines' promising KRAS inhibitors show potential in pancreatic cancer. See why we recommend a hold rating on ...

Revolution Medicines, Inc. (RVMD) has been on a downward spiral lately with significant selling pressure. After declining 7% over the past four weeks, the stock looks well positioned for a trend ...

Revolution Medicines, Inc. (RVMD) has been beaten down lately with too much selling pressure. While the stock has lost 7.8% over the past four weeks, there is light at the end of the tunnel as it ...

Revolution Medicines has a 52 week low of $27.40 and a 52 week high of $62.40. Revolution Medicines ( NASDAQ:RVMD – Get Free Report ) last released its earnings results on Wednesday, November 6th.

Revolution Medicines, Inc. has a 1-year low of $25.93 and a 1-year high of $62.40. Revolution Medicines ( NASDAQ:RVMD – Get Free Report ) last posted its earnings results on Wednesday, November 6th.

To access the live webcast of the presentation, please visit the “Events & Presentations” page of Revolution Medicines’ website at Additionally, a replay of the webcast will be available on the ...

Revolution Medicines, Inc. (NASDAQ:RVMD), a biotechnology company focused on developing novel therapies for cancer, has been making significant strides in its clinical pipeline, particularly in the ...